These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19059777)

  • 41. Trypanosoma brucei dihydrofolate reductase-thymidylate synthase: gene isolation and expression and characterization of the enzyme.
    Gamarro F; Yu PL; Zhao J; Edman U; Greene PJ; Santi D
    Mol Biochem Parasitol; 1995 Jun; 72(1-2):11-22. PubMed ID: 8538681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative.
    Popov VM; Chan DC; Fillingham YA; Atom Yee W; Wright DL; Anderson AC
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4366-70. PubMed ID: 16750361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
    Gaffar FR; Wilschut K; Franssen FF; de Vries E
    Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights into antifolate resistance from malarial DHFR-TS structures.
    Yuvaniyama J; Chitnumsub P; Kamchonwongpaisan S; Vanichtanankul J; Sirawaraporn W; Taylor P; Walkinshaw MD; Yuthavong Y
    Nat Struct Biol; 2003 May; 10(5):357-65. PubMed ID: 12704428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
    Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
    Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
    Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
    Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a homodimeric dihydrofolate reductase-thymidylate synthase bifunctional enzyme.
    Trujillo M; Duncan R; Santi DV
    Protein Eng; 1997 May; 10(5):567-73. PubMed ID: 9215575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Selective Inhibitors of
    Sharma VK; Bharatam PV
    J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potency boost of a
    Aragaw WW; Lee BM; Yang X; Zimmerman MD; Gengenbacher M; Dartois V; Chui WK; Jackson CJ; Dick T
    Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34161270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase.
    Liang PH; Anderson KS
    Biochemistry; 1998 Sep; 37(35):12195-205. PubMed ID: 9724533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demonstration of synergistic effects of sulfonamides and dihydrofolate reductase/thymidylate synthase inhibitors against Neospora caninum tachyzoites in cultured cells, and characterization of mutants resistant to pyrimethamine.
    Lindsay DS; Butler JM; Rippey NS; Blagburn BL
    Am J Vet Res; 1996 Jan; 57(1):68-72. PubMed ID: 8720241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymidylate synthase-dihydrofolate reductase in protozoa.
    Ivanetich KM; Santi DV
    Exp Parasitol; 1990 Apr; 70(3):367-71. PubMed ID: 2178951
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Divergent regulation of dihydrofolate reductase between malaria parasite and human host.
    Zhang K; Rathod PK
    Science; 2002 Apr; 296(5567):545-7. PubMed ID: 11964483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
    Yuthavong Y; Yuvaniyama J; Chitnumsub P; Vanichtanankul J; Chusacultanachai S; Tarnchompoo B; Vilaivan T; Kamchonwongpaisan S
    Parasitology; 2005 Mar; 130(Pt 3):249-59. PubMed ID: 15796007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rational Design of Novel Allosteric Dihydrofolate Reductase Inhibitors Showing Antibacterial Effects on Drug-Resistant Escherichia coli Escape Variants.
    Srinivasan B; Rodrigues JV; Tonddast-Navaei S; Shakhnovich E; Skolnick J
    ACS Chem Biol; 2017 Jul; 12(7):1848-1857. PubMed ID: 28525268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Electrostatic channeling in P. falciparum DHFR-TS: Brownian dynamics and Smoluchowski modeling.
    Metzger VT; Eun C; Kekenes-Huskey PM; Huber G; McCammon JA
    Biophys J; 2014 Nov; 107(10):2394-402. PubMed ID: 25418308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New small-molecule inhibitors of dihydrofolate reductase inhibit Streptococcus mutans.
    Zhang Q; Nguyen T; McMichael M; Velu SE; Zou J; Zhou X; Wu H
    Int J Antimicrob Agents; 2015 Aug; 46(2):174-82. PubMed ID: 26022931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase.
    Gschwend DA; Sirawaraporn W; Santi DV; Kuntz ID
    Proteins; 1997 Sep; 29(1):59-67. PubMed ID: 9294866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.